- 期刊Journal of the science of food and agriculture(J Sci Food Agric)
- 发表时间2026-10-09
- 作者Liu Y, Qian H, Wu C, Wang A, Lu S, Sun Y, Du D, Lei Y, Shen X
- DOI10.1002/jsfa.71149
- PMID42851075
摘要机译
【背景】长期高脂饮食(HFD)摄入诱导的肥胖与代谢紊乱和肠道微生物群失调密切相关,尽管植物提取物显示出抗肥胖潜力,但microbiota-dependent机制和因果关系仍不完全了解。
是一种传统的药用和膳食植物,但其水提取物的代谢作用尚未得到系统评估。本研究调查了黄芪水提取物(ASAE)的抗肥胖作用,并确定肠道微生物群重塑是否介导其代谢益处。HFD诱导的肥胖小鼠用ASAE治疗并进行全面的代谢表型。
采用超高效液相色谱结合四极飞行时间质谱对ASAE的化学成分进行表征,分别采用16S rRNA基因测序、非靶向代谢组学和RNA测序分析肠道微生物群组成、粪便代谢组谱和脂肪组织转录组,并进行粪便微生物群移植评估microbiota-dependent因果关系。
[结果]ASAE显著改善HFD喂养小鼠的糖耐量、胰岛素敏感性、血脂异常和肝脂肪变性,而不影响食物摄入。ASAE显着重塑肠道微生物群结构和粪便代谢组谱,特别是调节类固醇和脂质相关代谢物。
脂肪转录组分析显示ASAE逆转了HFD诱导的与免疫激活和脂质代谢功能障碍相关的转录程序。重要的是,来自ASAE治疗的供体的微生物群移植概括了肥胖受体小鼠的这些代谢改善,显示出microbiota-dependent效果。
[结论]ASAE通过肠道微生物群介导的机制减轻HFD诱导的肥胖,提供了将微生物重塑与宿主代谢改善联系起来的因果证据。这些发现突出表明ASAE是一种有前途的微生物群靶向肥胖干预措施。©2026年化学工业学会。
展开英文摘要原文
【BACKGROUND】Obesity induced by long-term high-fat diet (HFD) consumption is closely associated with metabolic disorders and gut microbiota dysbiosis. Although plant-derived extracts show anti-obesity potential, microbiota-dependent mechanisms and causal relevance remain incompletely understood. Astragalus sinicus L. is a traditional medicinal and dietary plant, yet the metabolic effects of its aqueous extract have not been systematically evaluated. This study investigated the anti-obesity effects of an aqueous extract of Astragalus sinicus (ASAE) and determined whether gut microbiota remodeling mediates its metabolic benefits. HFD-induced obese mice were treated with ASAE and subjected to comprehensive metabolic phenotyping. The chemical composition of ASAE was characterized by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Gut microbiota composition, fecal metabolomic profiles, and adipose tissue transcriptomes were analyzed using 16S rRNA gene sequencing, untargeted metabolomics, and RNA sequencing, respectively. Fecal microbiota transplantation was performed to assess microbiota-dependent causality.
【RESULTS】ASAE significantly improved glucose tolerance, insulin sensitivity, dyslipidemia, and hepatic steatosis in HFD-fed mice without affecting food intake. ASAE markedly reshaped gut microbiota structure and fecal metabolomic profiles, particularly regulating steroid- and lipid-related metabolites. Adipose transcriptomic analysis revealed that ASAE reversed HFD-induced transcriptional programs associated with immune activation and lipid metabolic dysfunction. Importantly, transplantation of microbiota from ASAE-treated donors recapitulated these metabolic improvements in obese recipient mice, demonstrating a microbiota-dependent effect.
【CONCLUSION】ASAE alleviates HFD-induced obesity through gut microbiota-mediated mechanisms, providing causal evidence linking microbial remodeling to host metabolic improvement. These findings highlight ASAE as a promising microbiota-targeted intervention for obesity. © 2026 Society of Chemical Industry.
相关物质
本页由系统自动抓取 PubMed 元数据生成;标题与摘要版权归原作者与期刊所有;机译内容仅供参考,请以英文原文为准;收录不代表本站观点,亦不作为用药或医疗建议。